Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,3-dihydro-6-methyl-7-hydroxy-3-(4-chlorophenyl)furo(3,4-d)pyridine
2. Bn 1270
3. Bn-1270
4. Cicletanide
5. Cicletanine Hydrochloride
6. Cycletanide
7. Justar
8. Tenstaten
1. Cycletanide
2. 89943-82-8
3. Bn-1270
4. Win 90,000
5. Win-90000
6. Chg7qc509w
7. 3-(4-chlorophenyl)-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol
8. Tenstaten
9. Justar
10. (+/-)bn-1270
11. Cicletanina
12. Cicletaninum
13. Cicletaninum [latin]
14. (+/-)-cicletanine
15. Cicletanina [spanish]
16. Unii-chg7qc509w
17. Cicletanine [usan:inn:ban]
18. Cicletanine [mi]
19. Cicletanine [inn]
20. Cicletanine (usan/inn)
21. Cicletanine [usan]
22. (+-)-bn-1270
23. Cicletanine [mart.]
24. Schembl49794
25. Cicletanine [who-dd]
26. Chembl191886
27. (r)-(-)-cicletanine
28. Dtxsid70868972
29. Chebi:135078
30. (+-)-3-(p-chlorophenyl)-1,3-dihydro-6-methylfuro(3,4-c)pyridin-7-ol
31. Akos022665941
32. Db12766
33. Bn-50417
34. Bn-50418
35. Ds-017342
36. D03487
37. (+/-)-bn-1270
38. Q5119443
39. 3-(4-chlorophenyl)-6-methyl-1h,3h-furo[3,4-c]pyridin-7-ol
40. Furo(3,4-c)pyridin-7-ol, 3-(4-chlorophenyl)-1,3-dihydro-6-methyl-, (+-)-
| Molecular Weight | 261.70 g/mol |
|---|---|
| Molecular Formula | C14H12ClNO2 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 261.0556563 g/mol |
| Monoisotopic Mass | 261.0556563 g/mol |
| Topological Polar Surface Area | 42.4 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 294 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Diuretics
Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)
C - Cardiovascular system
C03 - Diuretics
C03B - Low-ceiling diuretics, excl. thiazides
C03BX - Other low-ceiling diuretics
C03BX03 - Cicletanine
ABOUT THIS PAGE
A Cicletanine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cicletanine, including repackagers and relabelers. The FDA regulates Cicletanine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cicletanine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cicletanine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cicletanine supplier is an individual or a company that provides Cicletanine active pharmaceutical ingredient (API) or Cicletanine finished formulations upon request. The Cicletanine suppliers may include Cicletanine API manufacturers, exporters, distributors and traders.
click here to find a list of Cicletanine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cicletanine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cicletanine active pharmaceutical ingredient (API) in detail. Different forms of Cicletanine DMFs exist exist since differing nations have different regulations, such as Cicletanine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cicletanine DMF submitted to regulatory agencies in the US is known as a USDMF. Cicletanine USDMF includes data on Cicletanine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cicletanine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cicletanine suppliers with USDMF on PharmaCompass.
Cicletanine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cicletanine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cicletanine GMP manufacturer or Cicletanine GMP API supplier for your needs.
A Cicletanine CoA (Certificate of Analysis) is a formal document that attests to Cicletanine's compliance with Cicletanine specifications and serves as a tool for batch-level quality control.
Cicletanine CoA mostly includes findings from lab analyses of a specific batch. For each Cicletanine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cicletanine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cicletanine EP), Cicletanine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cicletanine USP).
LOOKING FOR A SUPPLIER?
